Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Nuformix Plc (NFX) Share Price & Analysis

10 Followers

NFX Stock Chart & Stats

GBX 0.10-GBX 0.01(-6.54%)
At close: 4:30 PM GMT
0.1 p0.125 p0.15 p0.175 pAug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
GBX 0.09 - GBX 0.11
52-Week Range
GBX 0.09 - GBX 0.56
Previous Close
GBX 0.11
Volume
N/A
Average Volume (3M)
18.04M
Market Cap
GBP 2.79M
Enterprise Value
GBP 2.97T
Total Cash (Recent Filing)
GBP 930.28K
Total Debt (Recent Filing)
GBP 0
Price to Earnings (P/E)
―
Beta
-0.23
Next Earnings
Feb 03, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

The absence of debt limits interest obligations and refinancing exposure, giving Nuformix greater flexibility than a similarly loss-making company with leverage. This provides some capacity to direct future funding toward development activities, although the small asset base remains a constraint.

Focused Inhaled Drug Pipeline

A focused inhaled-therapy strategy gives Nuformix a defined scientific direction in respiratory and fibrotic lung diseases. Improving local delivery and reducing systemic exposure could create product differentiation if clinical development validates the formulations and attracts commercial partners.

Lower 2025 Net Loss

The substantial reduction in annual net loss suggests that the company may have tightened costs or benefited from fewer exceptional pressures. If maintained, a smaller loss base could extend available resources and reduce the funding required to advance its development pipeline.

Bears Say

No Recent Revenue

Persistent zero revenue indicates that Nuformix has not yet established a meaningful commercial or partnering income stream. This leaves near-term progress dependent on advancing drug candidates toward licensing, milestones, or royalties rather than funding operations through recurring sales.

Persistent Cash Burn

Ongoing negative operating and free cash flow means the company consumes cash while its pipeline remains under development. Continued burn increases dependence on external funding and could restrict the pace of research, clinical work, or partnership activity if financing is not secured.

Shrinking Financial Base

Although Nuformix has no debt, the material contraction in equity and assets reduces its financial buffer against continuing losses and development costs. A smaller capital base can limit strategic flexibility and make future funding more important to sustaining the business.

Nuformix Plc News

NFX FAQ

What was Nuformix Plc’s price range in the past 12 months?
Nuformix Plc lowest share price was 0.09 p and its highest was 0.56 p in the past 12 months.
What is Nuformix Plc’s market cap?
Nuformix Plc’s market cap is £2.79M.
When is Nuformix Plc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nuformix Plc’s earnings last quarter?
Nuformix Plc released its earnings results on May 28, 2026. The company reported 0 p earnings per share for the quarter.
Is Nuformix Plc overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nuformix Plc pay dividends?
Nuformix Plc does not currently pay dividends.
What is Nuformix Plc’s EPS estimate?
Nuformix Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuformix Plc have?
Nuformix Plc has 2,609,750,000 shares outstanding.
What happened to Nuformix Plc’s price movement after its last earnings report?
Nuformix Plc reported an EPS of 0 p in its last earnings report. Following the earnings report the stock price went down -2.941%.
Which hedge fund is a major shareholder of Nuformix Plc?
Currently, no hedge funds are holding shares in GB:NFX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology